NEW YORK – Immune disease prognostic firm PredictImmune announced on Thursday a collaboration with the Crohn's & Colitis Foundation to validate the company's PredictSure IBD test in a diverse patient population.
NEW YORK – Immune disease prognostic firm PredictImmune announced on Thursday a collaboration with the Crohn's & Colitis Foundation to validate the company's PredictSure IBD test in a diverse patient population.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.